Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,872.16
      -2.95%
      US Tech 100
      20,752.80
      0.46%
      Dow Jones
      42,326.87
      -2.58%
      Brent Oil
      72.945
      0.29%
      Bitcoin
      102,419.42
      2.35%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Marinus Pharmaceuticals Inc (MRNS)

      7. Marinus Pharmaceuticals Inc (MRNS) Financials

      Marinus Pharmaceuticals Inc

      Marinus Pharmaceuticals Inc (MRNS)

      -3x Mrna
      0.2436
      -0.0034
      (-1.38%)
      Closed December 18 4:00PM
      Delayed by 15 minutes
      0.2652
      0.0216
      ( 8.87% )
      Pre Market: 5:52AM
      Delayed by 15 minutes

      Marinus Pharmaceuticals Inc Financial Summary

      The current MRNS market cap is 14.64M. The company's latest EPS is USD -2.5624 and P/E is -0.09.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 7.34M7.19M7.68M8.06M8.54M
      Operating Income -31.65M-35.44M-35.82M-31.44M-21.88M
      Net Income -32.97M-41.77M-38.67M-35.83M-24.23M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 01.72M15.35M25.48M30.99M
      Operating Income -54.42M-67.94M-96.93M-112.79M-131.49M
      Net Income -54.12M-67.48M-98.78M-19.82M-141.41M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 200.81M170.91M137.35M87.08M63.62M
      Total Liabilities 146.27M154.14M153.78M134.43M130.36M
      Total Equity 54.54M16.77M-16.43M-47.35M-66.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 98.84M150.46M136.84M259.52M170.91M
      Total Liabilities 11.07M13.26M83.35M143.52M154.14M
      Total Equity 59.57M137.2M53.49M116M16.77M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -91.01M-118M-37.46M-68.3M-87.76M
      Investing -35.07M-28.61M20.89M29.85M28.73M
      Financing 25.97M26.63M257k-17.44M-19.37M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -48.63M-60.91M-55.48M-112.89M-118M
      Investing 3.88M-738k-1.42M105.77M-28.61M
      Financing 67.97M109.22M41.31M124.74M26.63M

      Stats and Ratios

      Market Cap 14.64M
      Price to Earnings Ratio -0.09
      Price to Sales Ratio 0.43
      Price to Cash Ratio 0.11
      Price to Book Ratio 0.79
      Dividend Yield -

      Share Statistics

      Shares Outstanding 55.19M
      Average Volume (1 week) 1.63M
      Average Volume (1 Month) 1.02M
      52 Week Change -97.05%
      52 Week High 11.26
      52 Week Low 0.2302
      Spread (Intraday) 0.03 (11.48%)

      Company Info

      Company Name Marinus Pharmaceuticals Inc
      Address 3411 silverside road tatnall building
      wilmington, delaware 19810
      Website https://www.marinuspharma.com
      Industry pharmaceutical preparations (2834)